Axsome Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 2830 www.axsome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics, Inc.

Is Axsome Therapeutics, Inc. (AXSM) the Best Performing Growth Stock in 2025? - Mar 14th, 2025 2:32 pm
AXSM Settles Sunosi Patent Litigation With Hikma Pharmaceuticals - Mar 6th, 2025 3:27 pm
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Hikma Pharmaceuticals USA - Mar 5th, 2025 12:00 pm
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission - Mar 3rd, 2025 12:00 pm
Why Axsome Therapeutics, Inc. (AXSM) is Skyrocketing So Far in 2025 - Mar 1st, 2025 10:04 pm
Axsome Therapeutics to Participate in Upcoming Investor Conferences - Feb 26th, 2025 12:00 pm
Axsome Therapeutics Full Year 2024 Earnings: EPS Misses Expectations - Feb 24th, 2025 6:36 pm
Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs - Feb 24th, 2025 6:34 pm
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors - Feb 24th, 2025 12:00 pm
Why Axsome Therapeutics, Inc. (AXSM) is the Best Performing Pharma Stock So Far in 2025 - Feb 23rd, 2025 8:09 pm
These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50 - Feb 21st, 2025 9:58 pm
Axsome Therapeutics, Inc. (AXSM): the Best Performing Healthcare Stock So Far in 2025 - Feb 19th, 2025 7:48 pm
Axsome Therapeutics Inc (AXSM) Q4 2024 Earnings Call Highlights: Robust Revenue Growth Amid ... - Feb 19th, 2025 7:03 am
Q4 2024 Axsome Therapeutics Inc Earnings Call - Feb 19th, 2025 6:06 am
Axsome Therapeutics (AXSM) Q4 2024 Earnings Call Transcript - Feb 18th, 2025 4:15 pm
Axsome Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - Feb 18th, 2025 12:00 pm
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy? - Feb 16th, 2025 2:45 pm
Why Axsome Therapeutics (AXSM) Is Advancing Today - Feb 11th, 2025 7:42 pm
Why Axsome Therapeutics Stock Is Soaring Today - Feb 11th, 2025 4:39 pm
Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva - Feb 11th, 2025 12:40 pm